Venus Concept Inc. Stock News

Fintel reports that Masters Capital Management Llc has filed a 13D/A form with the SEC disclosing ownership of 22,999,173 shares of Venus Concept Inc (VERO).

Venus Concept Inc. (NASDAQ:VERO ) Q3 2022 Earnings Conference Call November 10, 2022 5:00 PM ET Corporate Participants Rajiv De Silva - Chief Executive Officer Domenic Della Penna - Chief Financial Of

Which strategies are you using to trade penny stocks right now? The post How to Make Money With Penny Stocks in a Volatile Market appeared first on Penny Stocks to Buy, Picks, News and Information | P

Venus Concept Inc. (NASDAQ:VERO ) Q2 2022 Earnings Conference Call August 12, 2022 4:30 PM ET Company Participants Dom Serafino - CEO Domenic Penna - CFO Ross Portaro - President of Global Sales Confe

Venus Concept (VERO) delivered earnings and revenue surprises of -100% and 9.11%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that second quart

Venus Concept Inc. (NASDAQ:VERO ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants Dom Serafino - CEO Domenic Penna - CFO Ross Portaro - President of Global Sales Conferen

Venus Concept (VERO) delivered earnings and revenue surprises of -30% and 2.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

TORONTO, April 04, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that first quart

Venus Concept Inc. (VERO) CEO Dom Serafino on Q4 2021 Results - Earnings Call Transcript

Venus Concept (VERO) delivered earnings and revenue surprises of 33.33% and 0.41%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

TORONTO, March 21, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that managemen

TORONTO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that fourth quart

Venus Concept (VERO) has won FDA 510(k) clearance to market its Venus BlissMAX device in the U.S.BlissMAX is a medical aesthetic platform that serves as a comprehensive solution for

Venus Concept (VERO) filed with U.S. SEC to offer 13.6M shares including 9.8M shares and 3.8M shares issuable on conversion of outstanding shares of nonvoting convertible